Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Janssen
>
The infusion model is about to die
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="anonymous, post: 6140033"]We need to be honest here. Reps don’t work a full week and never did. The work load, thanks to partnering, is rediculous and most reps struggle to keep their manager busy on ride alongs. Sales reps could be reduced by 75% and have zero impact on sales. That goes for sales managers as well. Most of us have really forgotten how to really work. SMDs and NADs are on permanent vacation. HPADs are a joke. The facts speak loudly. Slash away without any repercussions.[/QUOTE]</p><p><br /></p>
[QUOTE="anonymous, post: 6140033"]We need to be honest here. Reps don’t work a full week and never did. The work load, thanks to partnering, is rediculous and most reps struggle to keep their manager busy on ride alongs. Sales reps could be reduced by 75% and have zero impact on sales. That goes for sales managers as well. Most of us have really forgotten how to really work. SMDs and NADs are on permanent vacation. HPADs are a joke. The facts speak loudly. Slash away without any repercussions.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Janssen
>
The infusion model is about to die
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Janssen
>
The infusion model is about to die
>